Report Company Directory

H-D INTERNATIONAL HOLDINGS GROUP

H-Farm

• H-Farm S.p.A.: 2 directors by SmartInsider
• Espresso | H-FARM | Hold | New campus to foster expansion in education services by Kepler Cheuvreux
• Espresso | H-FARM | Hold | FY results broadly in line, public tender offer on 2.5m shares by Kepler Cheuvreux
• Espresso | H-FARM | Hold | A flux of M&A activities by Kepler Cheuvreux
• Espresso | H-FARM | Hold | Expanding in consulting by Kepler Cheuvreux
• Espresso | H-FARM | Hold | Small acquisition in Education by Kepler Cheuvreux
• Espresso | H-FARM | Hold | Partial public tender offer on 2.5m shares at EUR0.85 by Kepler Cheuvreux
• Espresso | H-FARM | Hold | Higher-than-expected operating costs, TP trimmed by Kepler Cheuvreux

H-ONE CO LTD

• Auto parts sector: new MTP, shareholder return policies by Mizuho Securities
• 自動車部品セクターの新中計･資本政策･株主還元方針 by Mizuho Securities
• 自動車・自動車部品セクター: セミナー概要 by Mizuho Securities
• A broader look at the auto parts industry (Vol. 18) by Mizuho Securities
• 自動車部品セクターの投資視点: 調査活動報告と気付き Vol. 18 by Mizuho Securities
• A broader look at the auto parts industry (Vol. 17) by Mizuho Securities
• 自動車部品セクターの投資視点: 調査活動報告と気付き Vol. 17 by Mizuho Securities
• Ford Equity International Rating and Forecast Report by Ford Equity Research

H-SOURCE HOLDING

• H-Source Announces Closing of $1.15 Million Brokered Private Placement by GlobeNewsWire
• H-Source Announces Brokered Private Placement by GlobeNewsWire

H. LUNDBECK A/S

• Lundbeck – No Rating (Buy/DKK 72): Suspension of coverage by Nordea
• Lundbeck – Buy/DKK 71: US migraine KOL call suggests a clearly differentiated profile of Vyepti and very long stay-time by Nordea
• Lundbeck – Buy/DKK 71: CRL for Rexulti in PTSD - As expected, a non-event and no impact on estimates or valuation by Nordea
• Lundbeck – Buy/DKK 71: Another step in the right strategic direction - Moves to a partner sales model in 27 countries in Europe & IO, reduces workforce by ~11% by Nordea
• Lundbeck – Buy/DKK 69 (72): Trending towards another guidance hike by Nordea
• Lundbeck – Buy/DKK 72: Otsuka raises guidance in pre-release - notes strong performance for Rexulti and Abilify Maintena in the pharma business by Nordea
• Lundbeck – Buy/DKK 72: Strong performance continues for Vyepti, Rexulti and Abilify LAI franchise by Nordea
• Lundbeck - Buy/DKK 72 (70): Strong growth for strategic brands set to continue by Nordea
• Lundbeck - Buy : A very strong start to the year with Q1 ahead on all metrics - 2025 guidance raised by Nordea
• Lundbeck - Buy/DKK 70: Another strong Q1 expected for key brands by Nordea